{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:38:44Z","timestamp":1778888324836,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.pbb.2011.03.007","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:55:11Z","timestamp":1300305311000},"page":"559-569","source":"Crossref","is-referenced-by-count":27,"title":["Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment"],"prefix":"10.1016","volume":"98","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Volf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.03.007_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00210-007-0154-x","article-title":"Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic","volume":"375","author":"Abekawa","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0015","first-page":"93","article-title":"The \u201cdelayed onset\u201d of antipsychotic action\u2014an idea whose time has come and gone","volume":"31","author":"Agid","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pbb.2011.03.007_bb0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002130100818","article-title":"Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats","volume":"156","author":"Andersen","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02246096","article-title":"Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine","volume":"122","author":"Bakshi","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3565(24)37049-1","article-title":"Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist","volume":"283","author":"Bakshi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-3565(25)23831-9","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.108.139261","article-title":"Dews and pharmacological studies on behavior","volume":"326","author":"Barrett","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2009.09.044","article-title":"Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance","volume":"207","author":"Briody","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.007_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.103.057158","article-title":"Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats","volume":"308","author":"Culm","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0055","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.pbb.2005.05.011","article-title":"Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas","volume":"81","author":"Doat-Meyerhoefer","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.007_bb0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbr.2007.04.020","article-title":"The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats","volume":"181","author":"Feifel","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.007_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130051103","article-title":"The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating","volume":"146","author":"Feifel","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-006-0658-y","article-title":"The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice","volume":"191","author":"Fejgin","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0361-9230(90)90241-Q","article-title":"Startle response models of sensorimotor gating and habituation deficits in schizophrenia","volume":"25","author":"Geyer","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2011.03.007_bb0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004850-200609000-00003","article-title":"Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia","volume":"21","author":"Glick","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.007_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3956(98)00023-5","article-title":"New atypical antipsychotic medications","volume":"32","author":"Jibson","year":"1998","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2011.03.007_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/appi.ajp.162.5.939","article-title":"Evidence for onset of antipsychotic effects within the first 24 hours of treatment","volume":"162","author":"Kapur","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0115","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biopsych.2005.02.023","article-title":"Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended","volume":"57","author":"Leucht","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2003.09.013","article-title":"Effects of typical and atypical antipsychotic drugs on maternal behavior in postpartum female rats","volume":"70","author":"Li","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.03.007_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.npp.1301110","article-title":"Time course of the antipsychotic effect and the underlying behavioral mechanisms","volume":"32","author":"Li","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.007_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FBP.0b013e32832a8f66","article-title":"An investigation of the behavioral mechanisms of antipsychotic action using a drug\u2013drug conditioning paradigm","volume":"20","author":"Li","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FBP.0b013e3283243008","article-title":"Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus","volume":"20","author":"Li","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-010-1925-5","article-title":"Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning","volume":"212","author":"Li","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0893-133X(00)00147-0","article-title":"\u201cEarly\u201d and \u201clate\u201d effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits","volume":"23","author":"Martinez","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.007_bb0150","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0014-2999(95)00333-G","article-title":"Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors","volume":"280","author":"Maurel-Remy","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0269881109102546","article-title":"Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism","volume":"24","author":"Mead","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0165","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","article-title":"Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat","volume":"11","author":"Millan","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.007_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/PL00005194","article-title":"Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats","volume":"357","author":"Pietraszek","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0091-3057(01)00743-2","article-title":"Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.007_bb0185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(01)00744-4","article-title":"Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.007_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-7-4","article-title":"Early onset of treatment effects with oral risperidone","volume":"7","author":"Raedler","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430230110","article-title":"Prepulse inhibition as a screening test for potential antipsychotics","volume":"23","author":"Rigdon","year":"1991","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pbb.2011.03.007_bb0200","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-004-1897-4","article-title":"Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia","volume":"176","author":"Rueter","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pbb.2004.11.008","article-title":"Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats","volume":"80","author":"Schwabe","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.007_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2008.11.036","article-title":"Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs","volume":"602","author":"Sun","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2010.02.024","article-title":"Iptakalim: a potential antipsychotic drug with novel mechanisms?","volume":"634","author":"Sun","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.007_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.007_bb0220","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0022-3565(25)21289-7","article-title":"Seroquel restores sensorimotor gating in phencyclidine-treated rats","volume":"279","author":"Swerdlow","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0091-3057(93)90193-W","article-title":"Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia","volume":"44","author":"Swerdlow","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.007_bb0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0022-3565(25)23018-X","article-title":"Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat","volume":"256","author":"Swerdlow","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.007_bb0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","article-title":"Realistic expectations of prepulse inhibition in translational models for schizophrenia research","volume":"199","author":"Swerdlow","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.007_bb0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s007020200043","article-title":"Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats","volume":"109","author":"Wiley","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2011.03.007_bb0245","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0006-3223(98)00356-4","article-title":"Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats","volume":"46","author":"Yamada","year":"1999","journal-title":"Biol Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:37:33Z","timestamp":1741102653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0091305711000785"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.03.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}